Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Supplementation in Men With MCI
NCT00539305Phase 3Completed
- Sponsor
- University of Washington
- Start
- Jul 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in Mild Cognitive Impairment (MCI), Alzheimer's disease (AD), sponsored by University of Washington. Started Jul 2009; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Mild Cognitive Impairment (MCI)Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00539305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539305.